Compass Therapeutics, Inc. (CMPX)
6.18
-0.21
(-3.29%)
USD |
NASDAQ |
Feb 20, 12:32
Compass Therapeutics EPS Diluted (Quarterly) : -0.0845 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| ImmunityBio, Inc. | -0.071 |
| Biohaven Ltd. | -1.639 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.26M |
| Total Expenses (Quarterly) | 14.26M |
| Enterprise Value | 926.51M |
| Earnings Yield | -7.40% |
| Normalized Earnings Yield | -7.405 |